(Q30739162)

26 June 2017

1 reference

title

Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature (English)

1 reference

26 June 2017

1

Robert Zivadinov

1 reference

26 June 2017

Marino Zorzon

2

1 reference

26 June 2017

publication date

1 October 2002

1 reference

26 June 2017

published in

Journal of Neuroimaging

1 reference

26 June 2017

volume

12

1 reference

26 June 2017

issue

4

1 reference

26 June 2017

page(s)

302-309

1 reference

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2002.TB00137.X

Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2002.TB00137.X

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2002.TB00137.X

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2002.TB00137.X

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2002.TB00137.X

Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2002.TB00137.X

Whole brain volume changes in patients with progressive MS treated with cladribine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2002.TB00137.X

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2002.TB00137.X

10.1111/J.1552-6569.2002.TB00137.X

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference